Potential uses of modafinil in psychiatric disorders

Journal of Applied Research

Volumn 4, Issue 2, 2004, Pages 198-207

  Bransfield, Robert C ^a  

^a Riverview Medical Center   (United States)

Author keywords

Apathy; Executive dysfunction; Hypoarousal symptoms; Lyme disease; Modafinil

Indexed keywords

ALPRAZOLAM; AMFEBUTAMONE; BUSPIRONE; CITALOPRAM; CLONAZEPAM; DESIPRAMINE; DIAZEPAM; DONEPEZIL; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; GALANTAMINE; HYDROXYZINE; LAMOTRIGINE; LORAZEPAM; MIRTAZAPINE; MODAFINIL; OLANZAPINE; PAROXETINE; PLACEBO; QUETIAPINE; RISPERIDONE; SERTRALINE; TIAGABINE; TRANYLCYPROMINE; TRAZODONE; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE; ZIPRASIDONE;

ADOLESCENT; ADULT; AGED; APATHY; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG TOLERABILITY; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SCHOOL CHILD; SOMNOLENCE;

EID: 6344280858     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lin J-S, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci USA. 1996;93:14128-14133.
2. Scammell TE, Estabrooke IV, McCarthy MT, et al. Hypothalamic arousal regions are activated during modafinil-induced wakefulness. Neurosci. 2000;20:8620-8628.
3. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999;98:437-451.
4. Thomas RJ, Kwong K. Effects of modafinil on working memory load responses after overnight sleep deprivation: a functional magnetic resonance imaging study. Sleep. 2003;26(Suppl):A187-A188.
5. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol. 1998;43:88-97.
6. US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology. 2000;54:1166-1175.
7. Broughton RJ, Fleming JAE, George CFP, et al. Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology. 1997;49:444-451
8. Beusterien KM, Rogers AE, Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep. 1999;22:757-765.
9. Emsellem HA. Efficacy and safety profiles of Provigil (modafinil) maintained during long-term (40 and 88 weeks) treatment of excessive daytime sleepiness associated with narcolepsy [abstract]. Neurology. 2000;54(Suppl 3):A29.
10. Miller MM, Harsh J, Hirshkowitz M, Guilleminault C. Long-term efficacy and safety of modafinil for the treatment of excessive daytime sleepiness associated with narcolepsy. Sleep Med. 2000;1:231-243.
11. Hirshkowitz M, Schwartz J, Corser B, Sahota P. Long-term (136 weeks) safety and efficacy of modafinil for the treatment of excessive daytime sleepiness associated with narcolepsy [abstract]. Sleep. 2001;24(Suppl):A329- A330.
12. Moldofsky H, Broughton RJ, Hill JD. A randomized trial of the long-term, continued efficacy and safety of modafinil in narcolepsy. Sleep Med. 2000;1:109-116.
13. Pack AI, Black JE, Schwartz JRL, Matheson JK. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med. 2001;164:1675-1681.
14. Black J, Hirshkowitz M, Earl CQ, et al. Modafinil adjunctive therapy improves excessive sleepiness and quality of life in obstructive sleep apnea: a 12-month open-label study [abstract]. Sleep. 2003;26(Suppl):A270-A271.
15. Bastuji H, Jouvet M. Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12:695-700.
16. Rammohan KW, Rosenberg JH, Lynn DJ, et al. Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study. J Neurol Neurosurg Psychiatry. 2002;72:179-183.
17. Adler CH, Caviness JN, Hentz JG, et al. An open-label extension study of modafinil for the treatment of daytime sleepiness in patients with Parkinson's disease. Sleep. 2002;25(Suppl):A251-A252.
18. Adler CH, Caviness JN, Hentz JG, et al. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease. Mov Disord. 2003;18:287-293.
19. Högl B, Saletu M, Brandauer E, et al. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep. 2002;25:62-66.
20. Ondo WG, Atassi F, Vuong KD, Jankovic J. Excessive daytime sleepiness in Parkinson's disease: a double-blind placebo-controlled parallel design study of modafinil. Neurology. 2002;58(Suppl 3):A433-A434.
21. Pigeau R, Naitoh P, Buguet A, et al. Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature. J Sleep Res. 1995;4:212-228.
22. Stivalet P, Esquivié D, Barraud P-A, et al. Effects of modafinil on attentional processes during 60 hours of sleep deprivation. Hum Psychopharmacol Clin Exp. 1998;13:501-507.
23. Becker PM, Schwartz J, Feldman N, Hughes RJ. Effect of modafinil on mood and quality of life in patients with narcolepsy [poster]. Presented at: American Psychiatric Association 2002 Annual Meeting; May 18-23, 2002; Philadelphia, Pa.
24. Rugino TA, Copley TC. Effects of modafinil in children with attention-deficit/hyperactivity disorder: an open-label study. J Am Acad Child Adolesc Psychiatry. 2001;40:230-235.
25. Menza MA, Kaufman KR, Castellanos AM. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry. 2000;61:378-381.
26. Yu BP, Maguire GA. Can a wakefulness-promoting agent augment schizophrenia treatment? Curr Psychiatry. 2002;1:52-57.
27. Saletu B, Saletu M, Grunberger J, et al. Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil. Neuropsychobiology. 1993;27:26-39.
28. Cochran JW. Effect of modafinil on fatigue associated with neurological illnesses. J Chronic Fatigue Syndrome. 2001;8:65-70.
29. Markovitz PJ, Wagner S. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy. J Clin Psychopharmacology. 2003;23:1-3.